BioCentury
ARTICLE | Emerging Company Profile

Acorda Therapeutics Inc.

January 3, 1997 8:00 AM UTC

New York, N.Y.

Technology: 4-aminopyridine potassium channel blocker; myelinating monoclonal antibodies; cellular adhesion molecules for neuroregeneration, and antioxidant drug cocktail...